Lipocine, Inc. (LPCN)
2.315
+0.06
(+2.89%)
USD |
NASDAQ |
Sep 10, 15:28
Lipocine Price to Book Value : 0.8768 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 0.8522 |
| September 08, 2026 | 0.8938 |
| September 04, 2026 | 0.9279 |
| September 03, 2026 | 0.9166 |
| September 02, 2026 | 0.8919 |
| September 01, 2026 | 0.8711 |
| August 31, 2026 | 0.8484 |
| August 28, 2026 | 0.8219 |
| August 27, 2026 | 0.8446 |
| August 26, 2026 | 0.8143 |
| August 25, 2026 | 0.8143 |
| August 24, 2026 | 0.7802 |
| August 21, 2026 | 0.7916 |
| August 20, 2026 | 0.7916 |
| August 19, 2026 | 0.7764 |
| August 18, 2026 | 0.7726 |
| August 17, 2026 | 0.7764 |
| August 14, 2026 | 0.7992 |
| August 13, 2026 | 0.7802 |
| August 12, 2026 | 0.7802 |
| August 11, 2026 | 0.7916 |
| August 10, 2026 | 0.7954 |
| August 07, 2026 | 0.8067 |
| August 06, 2026 | 0.8067 |
| August 05, 2026 | 0.8219 |
| Date | Value |
|---|---|
| August 04, 2026 | 0.8067 |
| August 03, 2026 | 0.7992 |
| July 31, 2026 | 0.8029 |
| July 30, 2026 | 0.7992 |
| July 29, 2026 | 0.784 |
| July 28, 2026 | 0.8105 |
| July 27, 2026 | 0.8105 |
| July 24, 2026 | 0.7878 |
| July 23, 2026 | 0.8295 |
| July 22, 2026 | 0.8446 |
| July 21, 2026 | 0.8295 |
| July 20, 2026 | 0.8143 |
| July 17, 2026 | 0.8446 |
| July 16, 2026 | 0.8673 |
| July 15, 2026 | 0.8938 |
| July 14, 2026 | 0.8749 |
| July 13, 2026 | 0.8901 |
| July 10, 2026 | 0.9128 |
| July 09, 2026 | 0.9355 |
| July 08, 2026 | 0.9241 |
| July 07, 2026 | 0.9355 |
| July 06, 2026 | 0.9355 |
| July 02, 2026 | 0.9052 |
| July 01, 2026 | 0.9317 |
| June 30, 2026 | 0.9696 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.553 |
| ANI Pharmaceuticals, Inc. | 2.713 |
| Corcept Therapeutics, Inc. | 17.49 |
| Veru, Inc. | 1.496 |
| Eli Lilly & Co. | 31.24 |
Price to Book Value Related Metrics
| PS Ratio | 9.634 |
| PEG Ratio | -0.0103 |
| Price | 2.315 |
| Earnings Yield | -80.52% |
| Market Cap | 19.09M |
| PEGY Ratio | -0.0103 |